Compagnie Lombard Odier SCmA’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-2,000
Closed -$156K – 949
2016
Q2
$156K Sell
2,000
-10,000
-83% -$713K ﹤0.01% 509
2016
Q1
$660K Sell
12,000
-13,000
-52% -$708K 0.02% 307
2015
Q4
$1.54M Hold
25,000
– – 0.05% 189
2015
Q3
$1.58M Hold
25,000
– – 0.06% 169
2015
Q2
$1.83M Buy
25,000
+23,000
+1,150% +$1.66M 0.07% 175
2015
Q1
$131K Hold
2,000
– – ﹤0.01% 596
2014
Q4
$130K Sell
2,000
-4,282
-68% -$276K 0.01% 500
2014
Q3
$377K Hold
6,282
– – 0.02% 383
2014
Q2
$436K Hold
6,282
– – 0.02% 354
2014
Q1
$411K Buy
6,282
+2,000
+47% +$130K 0.02% 359
2013
Q4
$265K Buy
+4,282
New +$248K 0.01% 458

Other funds holding STJ

Compagnie Lombard Odier SCmA's STJ Position: Q3 2016 in Review

Compagnie Lombard Odier SCmA sold out of St Jude Medical (STJ) in Q3 2016, closing a stake of 2,000 shares — an estimated $156K sold.

Compagnie Lombard Odier SCmA first reported a position in STJ in Q4 2013 and held it in 11 quarters. The position peaked at $1.83M in Q2 2015. 571 funds tracked by Wall St. Rank hold STJ as of Q3 2016.

  • Compagnie Lombard Odier SCmA reported no remaining St Jude Medical position as of Q3 2016 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 2,000 St Jude Medical shares in Q3 2016, an estimated $156K.
  • Compagnie Lombard Odier SCmA first reported a position in St Jude Medical in Q4 2013 and held it in 11 quarters.
  • Compagnie Lombard Odier SCmA's St Jude Medical position peaked at $1.83M in Q2 2015.
  • 571 funds tracked by Wall St. Rank held St Jude Medical as of Q3 2016.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q3 2016, filed 14 Nov 2016.